Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • pmiguel
    replied
    What is the N50 of your 15X assembly?
    I would suggest using BWA or Bowtie2 to map your reads against your transcriptome. See what percent map.
    Of course, depending on how "allo" your three sub-genomes are, there could be complexities there.
    --
    Phillip
    Last edited by pmiguel; 01-07-2015, 12:20 PM.

    Leave a comment:


  • Brian Bushnell
    replied
    I would shred the transcriptome into pieces (~300bp or so) and map them to the genome, then calculate coverage.

    Leave a comment:


  • Blat of transcriptome to genome gave 70% hits! reality?

    I work on an auto-allo hexaploid plant species with a genome size estimated to be about 2.1 Gb. We have an excellent transcriptome assembly from four different experiments that produced about 600,000 contigs with an N50 of over 1600 bases and a CEGMA run showed 98% representation at full length and 100% representation at partial. We also have PE100 genomic sequence data from 4 different libraries from 300-400 bases in size that gives us about 15X coverage (based on kmer representation analysis). For kicks, I used BLAT to see how many genomic fragments would map to my assembled transcriptome, and got (what to me seems) a surprising number of hits. Well over 70% of the genomic fragments had hits to the transcriptome. Is this likely real, or is there something about the BLAT program that would produce a high number of spurious hits? I counted only the unique hits, so this isn't due to genomic fragments having multiple hits to the transcriptome. Thoughts? Is there a better way to determine the percentage of the genome represented in my transcriptome?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...